News

Pharmabiz35m
Sunshine Biopharma’s Canadian subsidiary, Nora Pharma launches biosimilar drug, Niopeg
Sunshine Biopharma’s Canadian subsidiary, Nora Pharma launches biosimilar drug, Niopeg: Fort Lauderdale, Florida Friday, July 4, 2025, 14:00 Hrs [IST] Sunshine Biopharma Inc., a ...
Pharmabiz1h
Jacobio Pharma submits phase I/II IND application for its BET inhibitor, JAB-8263 to treat autoimmune diseases to CDE in China
Jacobio Pharma submits phase I/II IND application for its BET inhibitor, JAB-8263 to treat autoimmune diseases to CDE in China: Beijing, Shanghai Friday, July 4, 2025, 13:00 Hrs [ ...
Pharmabiz1h
Pharmac South 2025 opened at Chennai Trade Centre today
Our Bureau, Chennai Friday, July 4, 2025, 12:45 Hrs [IST] Pharmac South 2025, the 10th edition of South India's high-power ...
Pharmabiz2h
NS Pharma announces alliance with Boston Children’s Hospital to develop new therapies for rare diseases
NS Pharma announces alliance with Boston Children’s Hospital to develop new therapies for rare diseases: Paramus, New Jersey Friday, July 4, 2025, 12:00 Hrs [IST] Paramus-headqu ...
Pharmabiz3h
Zyla Health expands in Southeast Asia, empowering patients with personalised digital therapeutics
Zyla Health expands in Southeast Asia, empowering patients with personalised digital therapeutics: Our Bureau, Mumbai Friday, July 4, 2025, 11:30 Hrs [IST] Zyla Health, India’s ...
Pharmabiz3h
US FDA clears Instil Bio’s IND application for AXN-2510, a PD-L1xVEGF bispecific antibody, for a phase 1 trial in relapsed/refractory solid tumours
US FDA clears Instil Bio’s IND application for AXN-2510, a PD-L1xVEGF bispecific antibody, for a phase 1 trial in relapsed/refractory solid tumours: Dallas Friday, July 4, 2025, ...
Pharmabiz4h
SonoClear receives US FDA breakthrough designation for its SonoClear system for use in intracranial ultrasound procedures
SonoClear receives US FDA breakthrough designation for its SonoClear system for use in intracranial ultrasound procedures: Oslo, Norway Friday, July 4, 2025, 10:00 Hrs [IST] SonoC ...
Pharmabiz5h
Novartis announces top-line results from phase III GCAptAIN study of Cosentyx in giant cell arteritis
Novartis announced top-line results from the phase III GCAptAIN study evaluating Cosentyx (secukinumab) in adults with newly diagnosed or relapsing giant cell arteritis (GCA). In the study, Cosentyx ...
Pharmabiz6h
Lifesciences industry adopts a wait-and-watch approach amid US tariff uncertainty: Aditya Sharma
Lifesciences industry adopts a wait-and-watch approach amid US tariff uncertainty: Aditya Sharma: Nandita Vijayasimha, Friday, July 4, 2025, 08:00 Hrs [IST] Lifesciences industry ...
Pharmabiz6h
Pharmac South 2025 to kick off today at Chennai Trade Centre
The 10th edition of Pharmac South, the high-powered pharmaceutical and nutraceutical trade show, will open its doors today at the Chennai Trade Centre at Nandambakkam. The two-day event, running ...
Pharmabiz6h
Pharma industry eyes secure graphics & continuous data protection amid QR code counterfeit surge
Pharma industry eyes secure graphics & continuous data protection amid QR code counterfeit surge: Nandita Vijayasimha, Bengaluru Friday, July 4, 2025, 08:00 Hrs [IST] The pharmace ...
Pharmabiz6h
India and Myanmar in talks to fast-track approval for pharma products in Myanmar
India and Myanmar in talks to fast-track approval for pharma products in Myanmar: Shardul Nautiyal, Mumbai Friday, July 4, 2025, 08:00 Hrs [IST] In a major development to boost ph ...